These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 7490441

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The macrolides: erythromycin, clarithromycin, and azithromycin.
    Alvarez-Elcoro S, Enzler MJ.
    Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
    [Abstract] [Full Text] [Related]

  • 4. The new macrolides. Azithromycin and clarithromycin.
    Kanatani MS, Guglielmo BJ.
    West J Med; 1994 Jan; 160(1):31-7. PubMed ID: 8128699
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
    Principi N, Esposito S.
    Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dirithromycin: a new macrolide.
    Wintermeyer SM, Abdel-Rahman SM, Nahata MC.
    Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
    Kelley MA, Weber DJ, Gilligan P, Cohen MS.
    Clin Infect Dis; 2000 Oct; 31(4):1008-11. PubMed ID: 11049784
    [Abstract] [Full Text] [Related]

  • 16. [Azithromycin: critical points].
    Philippon A, Cluzel R, Soussy CJ.
    Pathol Biol (Paris); 1995 Jun; 43(6):488-97. PubMed ID: 8539070
    [Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW.
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [Abstract] [Full Text] [Related]

  • 18. The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data.
    Carbon C, Poole MD.
    J Chemother; 1999 Apr; 11(2):107-18. PubMed ID: 10326741
    [Abstract] [Full Text] [Related]

  • 19. Macrolides in dermatology.
    Scheinfeld NS, Tutrone WD, Torres O, Weinberg JM.
    Dis Mon; 2004 Jul; 50(7):350-68. PubMed ID: 15280867
    [No Abstract] [Full Text] [Related]

  • 20. The role of azithromycin and clarithromycin in clinical practice.
    Goldman MP, Longworth DL.
    Cleve Clin J Med; 1993 Jul; 60(5):359-64. PubMed ID: 8403355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.